创伤失血性休克诊治中国急诊专家共识

2017-12-01 中国医师协会急诊医师分会 临床急诊杂志.2017.18(12):881-889.

创伤失血性休克是指创伤造成机体大量失血所致有效循环血量减少、组织灌注不足、细胞代谢紊乱和器官功能受损的病理生理过程。休克常常合并低血压[定义为收缩压<90mmHg(1mmHg=0.133kPa),脉压差<20mmHg,或原有高血压者收缩压自基线下降≥40mmHg]。30%~40%的创伤患者死亡是因为失血过多导致,这类患者中10%~20%因为错误的救治方案或不恰当的治疗措施而死亡。急性失血是创伤首要

中文标题:

创伤失血性休克诊治中国急诊专家共识

发布日期:

2017-12-01

简要介绍:

创伤失血性休克是指创伤造成机体大量失血所致有效循环血量减少、组织灌注不足、细胞代谢紊乱和器官功能受损的病理生理过程。休克常常合并低血压[定义为收缩压<90mmHg(1mmHg=0.133kPa),脉压差<20mmHg,或原有高血压者收缩压自基线下降≥40mmHg]。30%~40%的创伤患者死亡是因为失血过多导致,这类患者中10%~20%因为错误的救治方案或不恰当的治疗措施而死亡。急性失血是创伤首要的可预防性死因。及时、快速控制出血、纠正失血性休克对于严重创伤患者至关重要,可有效减少多器官功能障碍综合征(MODS)、降低病死率。

 

拓展指南:创伤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=创伤失血性休克诊治中国急诊专家共识)] GetToolGuiderByIdResponse(projectId=1, id=ddabd1c00152e6b8, title=创伤失血性休克诊治中国急诊专家共识, enTitle=, guiderFrom=临床急诊杂志.2017.18(12):881-889., authorId=null, author=, summary=创伤失血性休克是指创伤造成机体大量失血所致有效循环血量减少、组织灌注不足、细胞代谢紊乱和器官功能受损的病理生理过程。休克常常合并低血压[定义为收缩压<90mmHg(1mmHg=0.133kPa),脉压差<20mmHg,或原有高血压者收缩压自基线下降≥40mmHg]。30%~40%的创伤患者死亡是因为失血过多导致,这类患者中10%~20%因为错误的救治方案或不恰当的治疗措施而死亡。急性失血是创伤首要, cover=, journalId=null, articlesId=null, associationId=327, associationName=中国医师协会急诊医师分会, associationIntro=急诊科医师分会成立将推动急诊发展,为抢救患者生命,维护人民健康做出更大贡献,分会将就急诊科自身建设、行业发展、自律维权、科研合作、文化建设等问题展开工作,把分会建成为急诊科医师温馨家园!, copyright=0, guiderPublishedTime=Fri Dec 01 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>创伤失血性休克是指创伤造成机体大量失血所致有效循环血量减少、组织灌注不足、细胞代谢紊乱和器官功能受损的病理生理过程。休克常常合并低血压[定义为收缩压<90mmHg(1mmHg=0.133kPa),脉压差<20mmHg,或原有高血压者收缩压自基线下降≥40mmHg]。30%~40%的创伤患者死亡是因为失血过多导致,这类患者中10%~20%因为错误的救治方案或不恰当的治疗措施而死亡。急性失血是创伤首要的可预防性死因。及时、快速控制出血、纠正失血性休克对于严重创伤患者至关重要,可有效减少多器官功能障碍综合征(MODS)、降低病死率。 </P> <P> </P>拓展指南:<strong>与<font color=red>创伤</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e7b9d1c00152112c" title="中国城市创伤救治体系建设专家共识" target=_blank>中国城市创伤救治体系建设专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b2c051c0015098ec" title="《2017年美国东部创伤外科学会胰腺坏死手术治疗实践管理指南》摘译" target=_blank>《2017年美国东部创伤外科学会胰腺坏死手术治疗实践管理指南》摘译</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9c21b1c001a89312" title="中国重型颅脑创伤早期康复管理专家共识(2017)" target=_blank>中国重型颅脑创伤早期康复管理专家共识(2017)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=eec271c001a4e25a" title="儿童创伤急救早期处理专家共识" target=_blank>儿童创伤急救早期处理专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=504101c001a164e7" title="“创伤性脊柱脊髓损伤评估、治疗与康复”专家共识" target=_blank>“创伤性脊柱脊髓损伤评估、治疗与康复”专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%88%9B%E4%BC%A4" target=_blank>有关创伤更多指南</a></ul>, tagList=[TagDto(tagId=64871, tagName=创伤失血性休克)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8225, appHits=797, showAppHits=21, pcHits=4634, showPcHits=4019, likes=133, shares=65, comments=13, approvalStatus=1, publishedTime=Mon Dec 04 22:55:08 CST 2017, publishedTimeString=2017-12-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Dec 04 22:55:08 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:37:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=创伤失血性休克诊治中国急诊专家共识)])
创伤失血性休克诊治中国急诊专家共识
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010652, encodeId=637210106520d, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/d97dc8b6e4224aceae71f8bd323de65f/d278e0e0b7ed4232adc03b7d6ef47108.jpg, createdBy=685b3050239, createdName=837937182, createdTime=Mon Aug 23 16:27:39 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006778, encodeId=a5df1006e78b6, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e85569799, createdName=白衣斗士, createdTime=Tue Aug 10 22:18:09 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909061, encodeId=b0489090614e, content=坚持学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Fri Dec 18 09:47:16 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806290, encodeId=77ce8062906f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Wed Aug 05 12:06:51 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329207, encodeId=a66c32920ea8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=667d1980161, createdName=小哀烨, createdTime=Wed Jul 04 08:55:40 CST 2018, time=2018-07-04, status=1, ipAttribution=)]
    2021-08-23 837937182

    很好,学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010652, encodeId=637210106520d, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/d97dc8b6e4224aceae71f8bd323de65f/d278e0e0b7ed4232adc03b7d6ef47108.jpg, createdBy=685b3050239, createdName=837937182, createdTime=Mon Aug 23 16:27:39 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006778, encodeId=a5df1006e78b6, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e85569799, createdName=白衣斗士, createdTime=Tue Aug 10 22:18:09 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909061, encodeId=b0489090614e, content=坚持学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Fri Dec 18 09:47:16 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806290, encodeId=77ce8062906f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Wed Aug 05 12:06:51 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329207, encodeId=a66c32920ea8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=667d1980161, createdName=小哀烨, createdTime=Wed Jul 04 08:55:40 CST 2018, time=2018-07-04, status=1, ipAttribution=)]
    2021-08-10 白衣斗士

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010652, encodeId=637210106520d, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/d97dc8b6e4224aceae71f8bd323de65f/d278e0e0b7ed4232adc03b7d6ef47108.jpg, createdBy=685b3050239, createdName=837937182, createdTime=Mon Aug 23 16:27:39 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006778, encodeId=a5df1006e78b6, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e85569799, createdName=白衣斗士, createdTime=Tue Aug 10 22:18:09 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909061, encodeId=b0489090614e, content=坚持学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Fri Dec 18 09:47:16 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806290, encodeId=77ce8062906f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Wed Aug 05 12:06:51 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329207, encodeId=a66c32920ea8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=667d1980161, createdName=小哀烨, createdTime=Wed Jul 04 08:55:40 CST 2018, time=2018-07-04, status=1, ipAttribution=)]
    2020-12-18 1501e8a265m

    坚持学习!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010652, encodeId=637210106520d, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/d97dc8b6e4224aceae71f8bd323de65f/d278e0e0b7ed4232adc03b7d6ef47108.jpg, createdBy=685b3050239, createdName=837937182, createdTime=Mon Aug 23 16:27:39 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006778, encodeId=a5df1006e78b6, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e85569799, createdName=白衣斗士, createdTime=Tue Aug 10 22:18:09 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909061, encodeId=b0489090614e, content=坚持学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Fri Dec 18 09:47:16 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806290, encodeId=77ce8062906f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Wed Aug 05 12:06:51 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329207, encodeId=a66c32920ea8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=667d1980161, createdName=小哀烨, createdTime=Wed Jul 04 08:55:40 CST 2018, time=2018-07-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1010652, encodeId=637210106520d, content=很好,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/d97dc8b6e4224aceae71f8bd323de65f/d278e0e0b7ed4232adc03b7d6ef47108.jpg, createdBy=685b3050239, createdName=837937182, createdTime=Mon Aug 23 16:27:39 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006778, encodeId=a5df1006e78b6, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e85569799, createdName=白衣斗士, createdTime=Tue Aug 10 22:18:09 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909061, encodeId=b0489090614e, content=坚持学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/dbaf63b36e448a968c7f2a7ae332ccb0.jpg, createdBy=88832036049, createdName=1501e8a265m, createdTime=Fri Dec 18 09:47:16 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806290, encodeId=77ce8062906f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8332512312, createdName=124c08ddm99暂无昵称, createdTime=Wed Aug 05 12:06:51 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=329207, encodeId=a66c32920ea8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=667d1980161, createdName=小哀烨, createdTime=Wed Jul 04 08:55:40 CST 2018, time=2018-07-04, status=1, ipAttribution=)]
    2018-07-04 小哀烨

    学习一下

    0